172@29@17@249!~!172@29@0@53!~!|news|business|earnings|natco-pharma-consolidated-december-2019-net-sales-at-rs-482-20-crore-down-13-38-y-o-y-4938931.html!~!|controller|infinite_scroll_article.php
Moneycontrol
Financial Freedom Offer: Subscribe to Moneycontrol Pro and grab benefits worth ₹15,000/-
Last Updated : Feb 13, 2020 09:10 AM IST | Source: Moneycontrol.com

Natco Pharma Consolidated December 2019 Net Sales at Rs 482.20 crore, down 13.38% Y-o-Y

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reported Consolidated quarterly numbers for Natco Pharma are:

Net Sales at Rs 482.20 crore in December 2019 down 13.38% from Rs. 556.70 crore in December 2018.

Quarterly Net Profit at Rs. 104.50 crore in December 2019 down 34.48% from Rs. 159.50 crore in December 2018.

Close

EBITDA stands at Rs. 159.50 crore in December 2019 down 31.16% from Rs. 231.70 crore in December 2018.

Natco Pharma EPS has decreased to Rs. 5.75 in December 2019 from Rs. 8.65 in December 2018.

Natco Pharma shares closed at 708.75 on February 12, 2020 (NSE) and has given 29.35% returns over the last 6 months and 6.31% over the last 12 months.

Natco Pharma
Consolidated Quarterly Resultsin Rs. Cr.
Dec'19Sep'19Dec'18
Net Sales/Income from operations482.20485.70556.70
Other Operating Income------
Total Income From Operations482.20485.70556.70
EXPENDITURE
Consumption of Raw Materials75.7078.7082.90
Purchase of Traded Goods34.4031.5034.40
Increase/Decrease in Stocks-18.609.00-12.30
Power & Fuel------
Employees Cost97.80102.4093.30
Depreciation25.4021.9020.70
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses164.20129.80150.00
P/L Before Other Inc., Int., Excpt. Items & Tax103.30112.40187.70
Other Income30.8033.2023.30
P/L Before Int., Excpt. Items & Tax134.10145.60211.00
Interest5.306.206.30
P/L Before Exceptional Items & Tax128.80139.40204.70
Exceptional Items------
P/L Before Tax128.80139.40204.70
Tax24.4021.7045.40
P/L After Tax from Ordinary Activities104.40117.70159.30
Prior Year Adjustments------
Extra Ordinary Items------
Net Profit/(Loss) For the Period104.40117.70159.30
Minority Interest0.101.300.20
Share Of P/L Of Associates------
Net P/L After M.I & Associates104.50119.00159.50
Equity Share Capital36.4036.4036.80
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS5.756.558.65
Diluted EPS5.736.538.63
EPS After Extra Ordinary
Basic EPS5.756.558.65
Diluted EPS5.736.538.63
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited

First Published on Feb 13, 2020 08:55 am
Sections